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Summary
How do proteins evolve novel functions? To address this
question, we are studying the evolution of a mammalian
toxin, the serine protease BLTX [1], from the salivary glands
of the North American shrew Blarina brevicauda. Here, we
examine the molecular changes responsible for promoting
BLTX toxicity. First, we show that regulatory loops sur-
rounding the BLTX active site have evolved adaptively via
acquisition of small insertions and subsequent accelerated
sequence evolution. Second, these mutations introduce a
novel chemical environment into the catalytic cleft of BLTX.
Third, molecular-dynamic simulations show that the
observed changes create a novel chemical and physical
topology consistent with increased enzyme catalysis.
Finally,we show that a toxic serineprotease fromthe Mexican
beaded lizard (GTX) [2] has evolved convergently through
almost identical functional changes. Together, these results
suggest that the evolution of toxicity might be predictable—
arising via adaptive structural modification of analogous
labile regulatory loops of an ancestral serine protease—and
thus might aid in the identification of other toxic proteins.
Results and Discussion
How proteins evolve novel functions in nature remains largely
unknown. One approach to addressing this question is to
study molecular changes that result in functional conver-
gence. Venom evolution provides an ideal system in which to
study genetic novelty because in many cases the proteins
involved in toxicity have been identified and have evolved
independently across a variety of animals [3]. Here we first
identify the molecular changes associated with the evolution
of toxicity in a shrew and then document its remarkable func-
tional convergence with a lizard venom.
Although venom has been well characterized in reptiles,
toxicity has also evolved in a number of mammals, most often
in insectivores of the order Soricomorpha—a venomous bite
has been verified in solenodons [4], Eurasian water shrews
[5], and the American short-tailed shrew (Blarina brevicauda)
[6, 7]. The initial characterization of the serine protease BLTX
from B. brevicauda [1] provided the first evidence for the
biochemical basis of shrew toxicity. Subsequently, a nontoxic
homolog, blarinasin-1, has been purified from B. brevicauda
salivary glands [8], and the sequence of an uncharacterized
*Correspondence: hoekstra@oeb.harvard.eduhomolog blarinasin-2 has been reported (Uniprot ID:
Q5FBW1). All three proteins show the highest sequence simi-
larity to mammalian glandular kallikrein-1 serine proteases [9]
(e.g., BLTX, blarinasin-1, and blarinasin-2 are 55.5%, 54.1%,
and 54.1% identical at the amino acid level to human kalli-
krein-1, respectively). Therefore the most recent common
ancestor of BLTX, blarinasin-1, and blarinasin-2 is probably
an ortholog of the kallikrein-1 gene.
Based on sequence comparisons of the three extant
B. brevicauda genes, we reconstructed their evolutionary
history: the duplication of the ancestral protein resulted in
BLTX and the ancestor to blarinasin-1 and -2, followed by
a more recent duplication yielding blarinasin-1 and -2, which
share high sequence identity (98.2% at the amino acid level).
Importantly, recent studies suggest that BLTX toxicity is due
to an increase in catalytic activity relative to its nontoxic
homologs, thereby flooding the circulatory system with the
catalytic byproduct bradykinin, which in high doses can lead
to paralysis and death [1, 2, 8]. Thus, the molecular changes
required for toxicity have probably occurred along the
BLTX lineage and are associated with an increase in enzyme
activity.
Insertions in BLTX Regulatory Loops May Promote
Toxicity
To identify changes that could contribute to the evolution of
toxicity, we first examined sequence differences between
BLTX and its nontoxic homologs. Using a combination of amino
acid and nucleotide sequence alignments (see the Supple-
mental Data available online) with mammalian kallikrein-1
enzymes, we find two independent in-frame insertions of
21 bp (insert 1: L115-M121 in BLTX) and 12 bp each (insert 2:
F125-K128) that flank a 9 bp conserved element present in all
kallikrein-1 genes (Figure 1A). We also identified two additional
in-frame insertions unique toB.brevicauda: a 9 bp element cor-
responding to residues N54-V56 (insert 3) and a 3 bp element
(S179) present only in BLTX (insert 4; Figure 1A). Because these
insertions are unique to B. brevicauda and shrews are nested
well within the mammalian phylogeny (Figure 1A), all four inser-
tions are probably derived in B. brevicauda.
To determine the functional significance, if any, of these
insertions, we first examined their position in the enzyme.
Intriguingly, all of these insertions occurred within three loops
that surround the active site, which is defined as the cleft
encompassing the conserved catalytic triad Asp-His-Ser [10]
(Figure 1B). Two of the insertions (insert 1 and 2) are found in
a well-characterized secondary structure (22 residues) termed
the ‘‘kallikrein loop,’’ [11] herein designated as loop 1. In kalli-
kreins, this loop contacts the substrate peptide above the
catalytic triad [10] and contributes to the enzyme’s specificity
and rate of catalysis [12, 13]. Moreover, variation within this
region is thought to contribute to kallikrein functional diversity
[13]—the 15 known human kallikrein paralogs differ in kalli-
krein loop length and amino acid composition, and this varia-
tion is thought to confer their distinct physiological roles [10].
The other two insertions are found in regions designated as
loop 2 (8 residues) and loop 3 (11 residues) that also surround
the catalytic triad (Figure 1B), and thus, they too are likely to
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Figure 1. Multiple Small Insertions Unique to Shrew Kallikrein Regulatory Loops
(A) Amino acid sequence alignment of Blarina brevicauda BLTX, blarinasin-1 (B1), and blarinasin-2 (B2) with 12 other mammalian kallikrein-1 enzymes and
human trypsin based on automated amino acid alignments and refined manually with nucleotide sequences (see Supplemental Data). Topology depicting
species relationships shown on left (from [22]). Four insertions are highlighted (yellow) and all occur in the regulatory loops (red boxes) surrounding the active
site.
(B) A 3D model of BLTX (constructed based on human kallikrein-3 structure, Protein Data Bank ID 2ZCK; [23]) shows insert position (yellow) in three (of five)
regulatory loops (red) above the catalytic triad Asp-His-Ser (blue) in the active site. A substrate analog (fluorogenic oligopeptide Mu-KGISSQY-AFC; orange)
is shown docked. Substrate is proximate to loop 1 (the kallikrein loop).
(C) The five regulatory loops (red), all of which experience positive selection, surround the active site.regulate enzyme activity. However, because the nontoxic blar-
inasin-1 also contains the same insertions as BLTX (with the
exception of insert 4 unique to BLTX), the presence of these
insertions alone is not sufficient to confer toxicity.
BLTX Regulatory Loops Evolved under Positive Selection
It then follows that, in addition to insertions, other mutations
may contribute to changes in theses regulatory loops and
hence enzyme activity. To determine whether positive selec-
tion has acted on the loops, we tested for an excess of nonsy-
nonymous mutations (Ka/Ks analysis) among BLTX, blarina-
sin-1, and blarinasin-2. When considering the entire protein
sequence, we did not find a deviation from neutral expectations
in any pairwise comparison (Table S1). Although this suggests
that overall the protein is evolving under purifying selection,
any localized signal would be obscured by averaging across
regions [14]. Therefore, we performed a Ka/Ks analysis on
three-dimensional (3D) structural regions (following [15]),
defined based on a BLTX protein model. Specifically, we tested
for positive selection on the region surrounding the active site,
which comprises five loops (1–5, total of 61 residues; Figure 2A,
Table S1) that are likely to affect substrate accessibilitybecause of their proximity to the active site. This region
includes loops 1–3, each containing an insertion unique to
shrews. Together, these five loops show evidence for positive
selection in a comparison between BLTX and blarinasin-1
(Ka/Ks = 1.6, G = 15.4, p < 0.001), and BLTX and blarinasin-2
(Ka/Ks = 1.4, G = 15.1, p < 0.001); analysis of each loop sepa-
rately is statistically challenging because individual loops are
short. Although BLTX and blarinasin-1 differ at only 32% of
amino acid sites overall, we find that the five loops have
changed nearly twice as much (62% across sites). Moreover,
a substantial fraction of these amino acid changes occurred
in the loop 1 and 2 insertions (7 of 10 and 2 of 5 sites, respec-
tively). Other regions of the protein do not show elevated rates
of sequence change (Table S1). The excess of derived amino-
acid changes in BLTX’s regulatory loops, many of which occur
in the loop 1 and 2 insertions, suggests that both the insertions
and the extensive sequence evolution in the regulatory loops
might be important for toxicity.
Novel Physicochemical Properties of the Regulatory Loops
In addition to showing an excess of amino acid mutations
in BLTX regulatory loops, we determined whether these
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Figure 2. Physicochemical Pattern of Hydropathy and Charge in Loops 1 and 2 Correlates with Toxicity in BLTX
(A) For each amino acid residue in loop 1 (the kallikrein loop), hydropathy (top) and charge (bottom) are shown for BLTX (black), blarinasin-1 (gray), and
blarinasin-2 (white). Charge was assigned as negative (21) if Asp or Glu; positive (+1) if Lys, Arg, or His; and neutral (0) for all other amino acids.
(B) Average hydropathy and charge plotted for BLTX, B2, and B1.
(C) Hydropathy (top) and charge (bottom) shown for each amino acid in loop 2.
(D) Average hydropathy and charge plotted for BLTX, B2, and B1.mutations share unique physicochemical properties. We quan-
tified two properties of amino acids relevant to protein func-
tion—hydropathy and charge—for each of the residues in the
five loops of BLTX, blarinasin-1, and blarinasin-2. Although
we did not find any strong differences in the physicochemical
properties among the three proteins in loops 3–5 (Table S2),
BLTX shows a dramatic shift in both hydropathy and charge
for both loop 1 and 2. Loop 1 is hydrophilic in both blarinasin-
1 and -2, but is strongly hydrophobic in BLTX (Figure 2A). In
addition, we found a difference in the average per residue
charge in loop 1: BLTX has an equal or more positively charged
amino acid at every site compared with blarinasin-1 and -2
(Figure 2A). The average per-residue charge value for BLTX is
positive (+0.09), whereas that for blarinasin-1 and -2 is negative
(20.27 and 20.23, respectively). Similar analysis on loop 2
reveals it is hydrophobic for both blarinasin-1 and -2, whereas
BLTX is strongly hydrophilic (Figure 2B). We also found
a concomitant difference in loop 2 charge. Most strikingly,
three sites that are neutrally charged in blarinasin-1 and -2(N49-L51) are positive in BLTX (R49-H51), and the only charged
site in blarinasin-1 and -2 loop 2 (D52) is neutral in BLTX (N52).
The average per residue charge value for loop 2 in BLTX is
strongly positive (+0.375), whereas that for blarinasin-1 and -2
is negative (20.13). Thus, BLTX loops 1 and 2 have evolved
distinct physicochemical properties from blarinasin-1 and -2:
loop 1 is hydrophobic, loop 2 is strongly hydrophilic, and
both are positively charged. Notably, physicochemical proper-
ties have changed only in the loops that acquired insertions.
Predicted Structural Changes Consistent with Increased
Catalysis
To determine to what extent, if any, the acquisition of inser-
tions and the novel physicochemical properties of the regula-
tory loops might result in topological changes that can lead to
increased catalysis, we subjected 3D models of human KLK1
(hKLK1), BLTX, blarinasin-1, and blarinasin-2 to molecular
dynamics (MD) simulations. Here, we report three distinct
Current Biology Vol 19 No 22
1928B1     B2    BX    H1
D
is
ta
nc
e 
(Å
)
+      +
+      +
-
B1                   B2                  BLTX               hKLK1
-
-      -
-      -
-
-      -
-      -
-
-      -
-      -
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
2
13
45
2
1
3
45
2
13
45
2
13
45
D
is
ta
nc
e 
(Å
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
All      1E1      1H      1E2        2         3         4         5
hKLK1
B1
B2
BLTX
A C
B D
Figure 3. Predicted Structural Changes in BLTX,
Blarinasin-1, Blarinasin-2, and Human Kallikrein-1
(A) Three-dimensional structures based on
molecular dynamics simulations are aligned and
oriented with the catalytic cleft in the foreground.
Loop 1 in B1 (blue), B2 (cyan), BLTX (red), and
human KLK1 (black) hover over the catalytic triad
(yellow spheres) to different degrees. All four loop
1 conformations are shown on the BLTX model
(gray).
(B) The distance (A˚) between the tip of loop 5
(magenta in panel A) and loop 1 was calculated
for B1, B2, BLTX, and human KLK1 (6 standard
deviation).
(C) Flexibility measurements for all five loops
(dark gray shade), the first extension, helical
region, and second extension regions of loop 1
(1E1, 1H, and 1E2, respectively), and loops 2–5
individually in blarinasin-1, blarinasin-2, BLTX,
and human kallikrein-1. Light gray shaded areas
(1E1, and loop 2) represent regions that differ in
both length and polarity between BLTX and
hKLK1, showing the most striking difference in
flexibility. Each point is an average distance and
error bars are standard errors.
(D) Electrostatic potential of the four proteins.
Red denotes negative charge/potential and blue
positive charge/potential. The top panel shows
the surface electrostatic potential of the 3D
protein models. Yellow circle demarks the active
site (docking site is at its center). The middle
panel highlights the contribution of the charged
residues in regulatory loops 1–5 (shown as
spheres) to the surface electrostatic potential around the active site. The catalytic triad is shown as yellow spheres. The bottom panel summarizes the simpli-
fied surface electrostatic potential and the active site charge of the four proteins, demonstrating how it can modulate accessibility of a positively charged
substrate.predicted structural changes to the BLTX active site that
together probably lead to increased catalysis.
We first tested if substrate accessibility may be increased by
a more exposed active site. Simulations reveal that loop 1 of
BLTX has a more compressed conformation relative to blarina-
sin-1 and -2, exposing the active site (Figure 3A). To estimate
the extent of active site occlusion by loop 1, we measured
the distance between the tip of loop 5 (S253 in BLTX, Y252 in
blarinasin-1 and -2) and the extended portion of loop 1 for
each protein. We find that the active site opening is signifi-
cantly larger in BLTX compared to blarinasin-1 and -2
(Figure 3B). Loop 1 in BLTX is further from the active site rela-
tive to blarinasin-1 and -2 by an average of 4.7 A˚ and 3.6 A˚,
respectively. The kallikrein loop has been shown to regulate
accessibility to the active site [10], and therefore a more com-
pressed conformation due to its increased hydrophobicity
probably increases catalytic rate, as seen in other enzymes
(e.g., [16]). However, the opening of the active site is not signif-
icantly different between BLTX and the nontoxic human KLK1
(Figure 3B), suggesting that active site accessibility alone is
not sufficient to cause toxicity and other changes unique to
BLTX are required.
Second, increased enzyme activity can also be modulated
by a more flexible protein structure that allows for rapid
conformational changes during catalysis [17]. Our simulations
also show that BLTX’s active site surface, as defined by the
five regulatory loops, is significantly more flexible than blarina-
sin-1, blarinasin-2, and especially hKLK1 (Figure 3C). Average
fluctuation per atom across regulatory loops is 1.7 A˚ for
BLTX but only 0.9 A˚ for hKLK1 (Mann-Whitney UA = 222883,
z = 16.06, p < 0.0001). Specifically, the two regulatory loopswith insertions show significant fluctuation relative to hKLK1:
loop 1 of BLTX has an average fluctuation per atom of 2.9 A˚
relative to 1.2 A˚ of the homologous region in hKLK1, and
loop 2 has 2.2 A˚ relative to 0.9 A˚ of hKLK1 (Figure 3B; Mann-
Whitney UA = 296, 538, z = 4.48, 8.3, p < 0.0001, respectively).
Two features, the increased length and the polarity of the regu-
latory loops, might give rise to increased flexibility by
improving solvent interactions and reducing the compactness
of the molecule [18] as is indeed the case for BLTX relative to
hKLK1 (Table S3).
Third, the charge distribution (e.g., surface electrostatic
potential) surrounding the active site, relative to the substrate,
is a third mechanism by which catalysis may be altered [19].
In BLTX, we find a dramatic shift toward a positive charge in
the loops that surround the active site—four of the five regula-
tory loops (loops 1, 2, 4, and 5) are positively charged—which
significantly alters the active site surface. In fact, although
as much as 40% (12 of 30) of the positively charged residues
in BLTX cluster within the five regulatory loops, only 8% (2 of
23) of the negatively charged residues are found in this region.
The trend is opposite for blarinasin-1 and -2, with the active
site surface holding only 21% (6 of 28) of the positively charged
and 31% (9 of 29) of the negatively charged residues. To visu-
alize the distribution of charged residues in the simulated
3D structures, we generated surface electrostatic potential
maps for each protein. Both blarinasin-1 and -2 exhibit a
predominantly negatively charged catalytic cleft (only loops
4 and 5 are positively charged) similar to hKLK1 (Figure 3C).
By contrast, for BLTX, the catalytic cleft is predominantly
positively charged, whereas the actual active site (at the
center) is negatively charged (Figure 3C). Biochemical
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Figure 4. Convergent Evolution of Venom in Shrews and Lizards
(A) Sequence alignment of reptilian kallikrein-like proteins from 12 Varanus species and GTX from the venomous Helodermata horridum. Topology showing
Varanus species relationships shown on left. Unique insertion in GTX of seven residues is labeled and highlighted in gray. The GTX insertion is downstream
of the conserved catalytic aspartate (in bold) and the kallikrein loop in mammalian homologs (top box), and nonoverlapping with the two BLTX insertions
(gray). The lizard insertion, along with upstream sequence excluding the conserved aspartate, forms an analogous regulatory loop to that found in mamma-
lian kallikreins (bottom box).
(B) Comparison of the average hydropathy and charge of 12 mammalian (including B1 and B2) and 12 reptilian kallikrein loops to the two toxic enzymes
(BLTX and GTX).
(C) Three-dimensional representations of the electrostatic potentials for BLTX and GTX in which red denotes negative charge/potential and blue positive
charge/potential. Yellow circles highlight the active site (top panel). Cartoon representation in the same orientation highlights the contribution of the charged
amino acid residues in the regulatory loops to surface potential. Loops are labeled with dashed circles (bottom panel). The catalytic triad is shown as yellow
spheres.characterization of BLTX has demonstrated a strong prefer-
ence for substrates (both natural and artificially synthesized)
that are positively charged at position 1 [1]; thus, a positively
charged surface surrounding a negatively charge active site
might serve to most efficiently direct the preferred substrate
toward the active site. This contrast between the surface and
active site charge thus might also contribute to BLTX’s
increased catalytic rate.
Convergent Evolution of BLTX and a Lizard Venom GTX
One way to link these molecular changes with a causal func-
tional effect is to demonstrate convergent evolution in other
kallikrein-like toxins. In other words, if the structural modifica-
tions and physicochemical characteristics of BLTX’s catalytic
cleft are important for the evolution of toxicity, then other toxickallikreins [2, 20] might have evolved via similar changes. To
test this prediction, we examined the evolution of the kalli-
krein-related serine protease GTX from the Mexican beaded
lizard (Heloderma horridum), which is thought to confer
toxicity by increased catalysis like BLTX [2]. First, like BLTX,
GTX carries a unique 21 bp insertion immediately adjacent to
loop 1 (just after the conserved aspartate, D96) [1]. We aligned
GTX with 12 other lizard kallikrein-related proteins to demon-
strate that the insertion is indeed unique to GTX (Figure 4A).
Notably, this insertion is different from, but proximate to, the
insertions found in loop 1 of BLTX. Second, GTX has also
evolved a largely hydrophobic (+0.17) and positively charged
(+0.07) loop 1 (defined as the original loop plus the seven
inserted downstream residues excluding the conserved
aspartate).
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performed similar physicochemical analysis for loop 1 in an
additional 12 mammalian and 12 reptilian kallikrein proteins
(Table S4), none of which are known to be toxic. We find that
a hydrophobic and positively charged loop 1 is unique to
BLTX and GTX (Figure 4B). Moreover, the physicochemical
character of the GTX loop is similar to BLTX—the portion of
the loop directly above the active site is hydrophobic and
neutrally charged, but the inserted region, as in BLTX, is posi-
tively charged (Figure 4C). Thus, the loop 1 structure from two
divergent toxic enzymes has independently increased in
length (via short insertions) and evolved convergent physico-
chemical properties.
To determine whether these sequence changes in GTX
result in changes in the 3D protein structure, we used MD
simulations to model GTX. We first found that, similar to
BLTX, the conformation of loop 1 promotes a more open active
site; the distance between the tip of loop 5 and loop 1 in GTX
is even larger (by an average of 3.5 A˚) than that of BLTX. In
addition, whereas in BLTX an increase in active-site exposure
is achieved via a helical and more compressed loop 1 confor-
mation (Figure 3A), in GTX increased exposure is due to a
collapsed and linear loop conformation that minimizes
hindrance of the active site by the loop (Figure 4C). Second,
the active site surface of GTX is similar in flexibility to BLTX
with an average fluctuation per atom across the loops of
1.4 6 0.004 A˚ (Table S2) and an even higher fluctuation of
loop 1 (1.9 6 0.011 A˚). Third, as in BLTX, surface electrostatic
potential analysis shows that the unique GTX active site
surface exhibits a trend similar to BLTX, with a distinct posi-
tively charged character around a negatively charged active
site (Figure 4C). Thus, unlike any other kallikrein-like enzymes
we examined, BLTX and GTX have evolved unique and similar
characteristics.
Conclusions
We have shown that venom proteins from two diverged phyla,
reptiles and mammals, have evolved independently from
ancestral kallikrein-related serine proteases via similar struc-
tural modifications, which might lead to the similar degrees
of toxicity of BLTX and GTX [1]. Parallel changes in the spatial
and physicochemical properties, clustered in functionally
important protein regions, also have been reported in the
evolution of novel chimeric genes [21]. In both BLTX and
GTX, novel insertions increase the length, and hence the
conformation, of the regulatory loops that surround the active
site. Amino acid mutations in these loops (and in the insertions)
have also altered the physicochemical properties and
topology of the active site, modifications that might increase
substrate accessibility and hence catalysis in three ways:
increased exposure of the active site, more flexibility in the
regulatory loops, and a change in the surface electrostatic
potential. Future functional studies will allow us to determine
the individual effects of these mutations on enzyme activity.
How repetitive, and thus predictable, is evolution? This
example of convergent molecular evolution of two kallikrein-
like toxins from distant species, together with other examples
from venom proteins in diverse lineages [3], suggests that
adaptation may be highly predictable. As such, these common
results might aid in the identification of other naturally occur-
ring toxic proteins from diverse species. For example, a kalli-
krein-like enzyme (KR-E-1) was recently isolated from the viper
Agkistrodon caliginosus [20], and the kallikrein loop of this
enzyme is highly enriched for positively charged residues(particularly lysine residues), a characteristic associated with
toxicity. Moreover, the convergent mechanisms for increased
catalytic activity described here might be more universal and
applicable to a broad range of enzymes, which have evolved
changes in catalysis rate. For example, enzymes from cold
adapted organisms have increased catalytic efficiency to
compensate for slower function in low temperatures through
mechanisms similar to those described here (e.g., [18, 19]).
Thus, the combination of population-genetic analyses and
protein modeling, together with previous biochemical studies
[1], allowed us to identify convergent structural changes asso-
ciated with the evolution of toxicity specifically, and with
increased catalysis more generally.
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Supplemental Data include Supplemental Experimental Procedures, four
tables, and one figure and can be found with this article online at http://
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